Novartis highlights its strong foundation for long-term, sustainable growth
- Details
- Category: Novartis
Today Novartis holds its third annual Meet Novartis Management event at its headquarters in Basel, Switzerland, giving investors and analysts the opportunity to meet with more than 20 top executives from Novartis Group, divisions and research.
Boehringer Ingelheim and BioMed X start new project to explore and develop unprecedented new treatment approaches for psychiatric diseases applying crowdsourcing
- Details
- Category: Boehringer Ingelheim
Boehringer Ingelheim and BioMed X announced today that they have established a new research team of outstanding scientists from around the world that will conduct research to identify novel approaches for the treatment of patients with psychiatric diseases.
AstraZeneca highlights continued progress of oncology pipeline at ASCO 2016
- Details
- Category: AstraZeneca
AstraZeneca and its global biologics research and development arm, MedImmune, will provide an update on their extensive oncology pipeline at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, USA, on 3-7 June 2016.
Merck and Pfizer to present Avelumab data in seven different cancers at ASCO annual meeting
- Details
- Category: Pfizer
Merck and Pfizer today announced that avelumab* presentations across seven different tumor types, including two oral presentations, will be featured at the 52nd American Society of Clinical Oncology (ASCO) Annual Meeting being held June 3-7, 2016, in Chicago, IL.
Novartis focuses Pharmaceuticals Division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology; appoints leaders to the Executive Committee of Novartis
- Details
- Category: Novartis
Novartis has announced changes to focus its Pharmaceuticals Division by creating two business units reporting to the CEO: Novartis Pharmaceuticals and Novartis Oncology. These business units will form the Innovative Medicines Division at Novartis.
Johnson & Johnson announces collaboration with HP Inc. subsidiary to create personalized health care solutions with 3D printing technologies
- Details
- Category: Johnson & Johnson
Johnson & Johnson (NYSE: JNJ) today announced a collaboration between Johnson & Johnson Services, Inc. and a subsidiary of HP Inc. The collaboration is focused on using 3D printing technologies to create better health care outcomes at reduced costs.
Novartis Foundation and partners launch innovative hypertension program in Vietnam
- Details
- Category: Novartis
On the occasion of World Hypertension Day 2016, the Novartis Foundation and its partners, including the international nonprofit organization PATH, are announcing the launch of the Ho Chi Minh City Communities for Healthy Hearts Program, which is designed to improve health outcomes of adults with hypertension living in low-income households in urban Vietnam.
More Pharma News ...
- Pfizer awards more than $1 million in metastatic breast cancer research funding
- Selumetinib granted Orphan Drug Designation in the US for adjuvant treatment of differentiated thyroid cancer
- Grants4Apps Accelerator 2016: You imagine, Bayer supports
- AstraZeneca completes acquisition of Takeda's respiratory business
- Ready. Raise. Rise. Campaign
- Pfizer reports first-quarter 2016 results
- Bristol-Myers Squibb reports first quarter financial results